Xiwu Liu, Bincan Jiang, Ailan Cheng, Youwei Guo, Lei Wang, Weidong Liu, Wen Yin, Yihan Li, Xingjun Jiang, Caiping Ren
OBJECTIVE: Our research group in the early stage identified CD109 as the target of aptamer S3 in nasopharyngeal carcinoma (NPC). This study was to use S3 to connect DNA tetrahedron (DT) and load doxorubicin (Dox) onto DT to develop a targeted delivery system, and explore whether S3-DT-Dox can achieve targeted therapy for NPC. METHODS: Aptamer S3-conjugated DT was synthesized and loaded with Dox. The effects of S3-DT-Dox on NPC cells were investigated with laser confocal microscopy, flow cytometry, and MTS assays...
December 12, 2023: Journal of Otolaryngology—Head & Neck Surgery